Company / Operating Income per Share
Lexaria Bioscience Corp. Operating Income per Share History
FY2015-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$0.36
FY2025
5-year range
-$1.11 / -$0.36
FY2021-FY2025
Trend
+54.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-1.11 to $-0.36 over the past 2 years.
Based on SEC 10-K filings.
-0.36 in FY2025.
Improved from $-1.11 to $-0.36 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 54.9% year-over-year.
- Peak operating income per share was recorded in FY2016.
- Lowest operating income per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.36 | +54.9% |
| FY2024 | -$0.81 | +27.4% |
| FY2023 | -$1.11 | -12.0% |
| FY2022 | -$0.99 | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2017 | - | - |
| FY2016 | -$0.05 | +0.6% |
| FY2015 | -$0.05 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026